STAAR Surgical (STAA) Competitors

$27.75 +0.30 (+1.09%)

Closing price 05/6/2026 04:00 PM Eastern

Extended Trading

$28.20 +0.45 (+1.61%)

As of 05:25 AM Eastern

STAA vs. MMSI, ICUI, HAE, XRAY, and NEOG

Should you be buying STAAR Surgical stock or one of its competitors? The main competitors of STAAR Surgical include Merit Medical Systems (MMSI), ICU Medical (ICUI), Haemonetics (HAE), DENTSPLY SIRONA (XRAY), and Neogen (NEOG). These companies are all part of the "health care supplies" industry.

How does STAAR Surgical compare to Merit Medical Systems?

STAAR Surgical (NASDAQ:STAA) and Merit Medical Systems (NASDAQ:MMSI) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, institutional ownership, analyst recommendations, media sentiment, earnings, profitability, valuation and dividends.

: STAAR Surgical presently has a consensus target price of $19.93, suggesting a potential downside of 28.19%. Merit Medical Systems has a consensus target price of $92.80, suggesting a potential upside of 50.58%. Given Merit Medical Systems' stronger consensus rating and higher probable upside, analysts clearly believe Merit Medical Systems is more favorable than STAAR Surgical.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
STAAR Surgical
2 Sell rating(s)
7 Hold rating(s)

2 Buy rating(s)

0 Strong Buy rating(s)
2.00
Merit Medical Systems
0 Sell rating(s)

3 Hold rating(s)

8 Buy rating(s)

0 Strong Buy rating(s)
2.73
: STAAR Surgical has a beta of 1.2, suggesting that its stock price is 20% more volatile than the S&P 500. Comparatively, Merit Medical Systems has a beta of 0.58, suggesting that its stock price is 42% less volatile than the S&P 500.
: Merit Medical Systems has higher revenue and earnings than STAAR Surgical. STAAR Surgical is trading at a lower price-to-earnings ratio than Merit Medical Systems, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
STAAR Surgical $239.44M 5.77 -$80.45M -$1.63 N/A
Merit Medical Systems $1.52B 2.43 $128.49M $2.31 26.68
: Merit Medical Systems has a net margin of 9.03% compared to STAAR Surgical's net margin of -33.60%. Merit Medical Systems' return on equity of 13.54% beat STAAR Surgical's return on equity.
Company Net Margins Return on Equity Return on Assets
STAAR Surgical -33.60% -10.03% -7.70%
Merit Medical Systems 9.03% 13.54% 7.94%
: In the previous week, Merit Medical Systems had 28 more articles in the media than STAAR Surgical. MarketBeat recorded 31 mentions for Merit Medical Systems and 3 mentions for STAAR Surgical. Merit Medical Systems' average media sentiment score of 0.77 beat STAAR Surgical's score of 0.00 indicating that Merit Medical Systems is being referred to more favorably in the news media.
Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
STAAR Surgical
0 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Merit Medical Systems
13 Very Positive mention(s)
6 Positive mention(s)
6 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
: 96.7% of STAAR Surgical shares are held by institutional investors. Comparatively, 99.7% of Merit Medical Systems shares are held by institutional investors. 0.6% of STAAR Surgical shares are held by company insiders. Comparatively, 0.7% of Merit Medical Systems shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
STAAR Surgical	2 Sell rating(s)	7 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.00
Merit Medical Systems	0 Sell rating(s)	3 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.73

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
STAAR Surgical	$239.44M	5.77	-$80.45M	-$1.63	N/A
Merit Medical Systems	$1.52B	2.43	$128.49M	$2.31	26.68

Company	Net Margins	Return on Equity	Return on Assets
STAAR Surgical	-33.60%	-10.03%	-7.70%
Merit Medical Systems	9.03%	13.54%	7.94%

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
STAAR Surgical	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Merit Medical Systems	13 Very Positive mention(s)	6 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Merit Medical Systems beats STAAR Surgical on 14 of the 16 factors compared between the two stocks.

How does STAAR Surgical compare to ICU Medical?

STAAR Surgical (NASDAQ:STAA) and ICU Medical (NASDAQ:ICUI) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their institutional ownership, earnings, risk, profitability, analyst recommendations, valuation, dividends and media sentiment.

: 96.7% of STAAR Surgical shares are owned by institutional investors. Comparatively, 96.1% of ICU Medical shares are owned by institutional investors. 0.6% of STAAR Surgical shares are owned by company insiders. Comparatively, 2.1% of ICU Medical shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
: ICU Medical has a net margin of 0.03% compared to STAAR Surgical's net margin of -33.60%. ICU Medical's return on equity of 7.33% beat STAAR Surgical's return on equity.
Company Net Margins Return on Equity Return on Assets
STAAR Surgical -33.60% -10.03% -7.70%
ICU Medical 0.03% 7.33% 3.72%
: STAAR Surgical has a beta of 1.2, indicating that its share price is 20% more volatile than the S&P 500. Comparatively, ICU Medical has a beta of 0.74, indicating that its share price is 26% less volatile than the S&P 500.
: In the previous week, STAAR Surgical and STAAR Surgical both had 3 articles in the media. ICU Medical's average media sentiment score of 0.67 beat STAAR Surgical's score of 0.00 indicating that ICU Medical is being referred to more favorably in the news media.
Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
STAAR Surgical
0 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
ICU Medical
1 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
: ICU Medical has higher revenue and earnings than STAAR Surgical. STAAR Surgical is trading at a lower price-to-earnings ratio than ICU Medical, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
STAAR Surgical $239.44M 5.77 -$80.45M -$1.63 N/A
ICU Medical $2.23B 1.34 $730K $0.02 5,979.50
: STAAR Surgical currently has a consensus target price of $19.93, indicating a potential downside of 28.19%. ICU Medical has a consensus target price of $169.00, indicating a potential upside of 41.32%. Given ICU Medical's stronger consensus rating and higher possible upside, analysts clearly believe ICU Medical is more favorable than STAAR Surgical.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
STAAR Surgical
2 Sell rating(s)
7 Hold rating(s)

2 Buy rating(s)

0 Strong Buy rating(s)
2.00
ICU Medical
1 Sell rating(s)

0 Hold rating(s)

2 Buy rating(s)

1 Strong Buy rating(s)
2.75

Company	Net Margins	Return on Equity	Return on Assets
STAAR Surgical	-33.60%	-10.03%	-7.70%
ICU Medical	0.03%	7.33%	3.72%

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
STAAR Surgical	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
ICU Medical	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
STAAR Surgical	$239.44M	5.77	-$80.45M	-$1.63	N/A
ICU Medical	$2.23B	1.34	$730K	$0.02	5,979.50

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
STAAR Surgical	2 Sell rating(s)	7 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.00
ICU Medical	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.75

Summary

ICU Medical beats STAAR Surgical on 12 of the 15 factors compared between the two stocks.

How does STAAR Surgical compare to Haemonetics?

Haemonetics (NYSE:HAE) and STAAR Surgical (NASDAQ:STAA) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, profitability, analyst recommendations, dividends, media sentiment, risk, valuation and institutional ownership.

: Haemonetics currently has a consensus target price of $82.78, indicating a potential upside of 57.61%. STAAR Surgical has a consensus target price of $19.93, indicating a potential downside of 28.19%. Given Haemonetics' stronger consensus rating and higher probable upside, equities analysts clearly believe Haemonetics is more favorable than STAAR Surgical.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Haemonetics
0 Sell rating(s)
4 Hold rating(s)

6 Buy rating(s)

1 Strong Buy rating(s)
2.73
STAAR Surgical
2 Sell rating(s)

7 Hold rating(s)

2 Buy rating(s)

0 Strong Buy rating(s)
2.00
: Haemonetics has a beta of 0.53, indicating that its stock price is 47% less volatile than the S&P 500. Comparatively, STAAR Surgical has a beta of 1.2, indicating that its stock price is 20% more volatile than the S&P 500.
: Haemonetics has a net margin of 13.31% compared to STAAR Surgical's net margin of -33.60%. Haemonetics' return on equity of 27.32% beat STAAR Surgical's return on equity.
Company Net Margins Return on Equity Return on Assets
Haemonetics 13.31% 27.32% 9.61%
STAAR Surgical -33.60% -10.03% -7.70%
: 99.7% of Haemonetics shares are owned by institutional investors. Comparatively, 96.7% of STAAR Surgical shares are owned by institutional investors. 1.8% of Haemonetics shares are owned by insiders. Comparatively, 0.6% of STAAR Surgical shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.
: In the previous week, Haemonetics had 3 more articles in the media than STAAR Surgical. MarketBeat recorded 6 mentions for Haemonetics and 3 mentions for STAAR Surgical. Haemonetics' average media sentiment score of 0.50 beat STAAR Surgical's score of 0.00 indicating that Haemonetics is being referred to more favorably in the media.
Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Haemonetics
2 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
STAAR Surgical
0 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
: Haemonetics has higher revenue and earnings than STAAR Surgical. STAAR Surgical is trading at a lower price-to-earnings ratio than Haemonetics, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Haemonetics $1.32B 1.85 $167.68M $3.63 14.47
STAAR Surgical $239.44M 5.77 -$80.45M -$1.63 N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Haemonetics	0 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.73
STAAR Surgical	2 Sell rating(s)	7 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.00

Company	Net Margins	Return on Equity	Return on Assets
Haemonetics	13.31%	27.32%	9.61%
STAAR Surgical	-33.60%	-10.03%	-7.70%

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Haemonetics	2 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
STAAR Surgical	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Haemonetics	$1.32B	1.85	$167.68M	$3.63	14.47
STAAR Surgical	$239.44M	5.77	-$80.45M	-$1.63	N/A

Summary

Haemonetics beats STAAR Surgical on 15 of the 17 factors compared between the two stocks.

How does STAAR Surgical compare to DENTSPLY SIRONA?

DENTSPLY SIRONA (NASDAQ:XRAY) and STAAR Surgical (NASDAQ:STAA) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, profitability, analyst recommendations, dividends, media sentiment, risk, valuation and institutional ownership.

: STAAR Surgical has lower revenue, but higher earnings than DENTSPLY SIRONA. STAAR Surgical is trading at a lower price-to-earnings ratio than DENTSPLY SIRONA, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
DENTSPLY SIRONA $3.68B 0.61 -$598M -$3.15 N/A
STAAR Surgical $239.44M 5.77 -$80.45M -$1.63 N/A
: DENTSPLY SIRONA has a beta of 0.93, indicating that its stock price is 7% less volatile than the S&P 500. Comparatively, STAAR Surgical has a beta of 1.2, indicating that its stock price is 20% more volatile than the S&P 500.
: DENTSPLY SIRONA currently has a consensus target price of $13.73, indicating a potential upside of 23.23%. STAAR Surgical has a consensus target price of $19.93, indicating a potential downside of 28.19%. Given DENTSPLY SIRONA's higher probable upside, equities analysts clearly believe DENTSPLY SIRONA is more favorable than STAAR Surgical.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
DENTSPLY SIRONA
3 Sell rating(s)
8 Hold rating(s)

3 Buy rating(s)

0 Strong Buy rating(s)
2.00
STAAR Surgical
2 Sell rating(s)

7 Hold rating(s)

2 Buy rating(s)

0 Strong Buy rating(s)
2.00
: DENTSPLY SIRONA has a net margin of -17.06% compared to STAAR Surgical's net margin of -33.60%. DENTSPLY SIRONA's return on equity of 18.02% beat STAAR Surgical's return on equity.
Company Net Margins Return on Equity Return on Assets
DENTSPLY SIRONA -17.06% 18.02% 5.02%
STAAR Surgical -33.60% -10.03% -7.70%
: In the previous week, DENTSPLY SIRONA had 16 more articles in the media than STAAR Surgical. MarketBeat recorded 19 mentions for DENTSPLY SIRONA and 3 mentions for STAAR Surgical. STAAR Surgical's average media sentiment score of 0.00 beat DENTSPLY SIRONA's score of -0.22 indicating that STAAR Surgical is being referred to more favorably in the news media.
Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
DENTSPLY SIRONA
0 Very Positive mention(s)
2 Positive mention(s)
12 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Neutral
STAAR Surgical
0 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
: 95.7% of DENTSPLY SIRONA shares are owned by institutional investors. Comparatively, 96.7% of STAAR Surgical shares are owned by institutional investors. 0.5% of DENTSPLY SIRONA shares are owned by insiders. Comparatively, 0.6% of STAAR Surgical shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
DENTSPLY SIRONA	$3.68B	0.61	-$598M	-$3.15	N/A
STAAR Surgical	$239.44M	5.77	-$80.45M	-$1.63	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
DENTSPLY SIRONA	3 Sell rating(s)	8 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.00
STAAR Surgical	2 Sell rating(s)	7 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.00

Company	Net Margins	Return on Equity	Return on Assets
DENTSPLY SIRONA	-17.06%	18.02%	5.02%
STAAR Surgical	-33.60%	-10.03%	-7.70%

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
DENTSPLY SIRONA	0 Very Positive mention(s)	2 Positive mention(s)	12 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral
STAAR Surgical	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

DENTSPLY SIRONA beats STAAR Surgical on 8 of the 15 factors compared between the two stocks.

How does STAAR Surgical compare to Neogen?

Neogen (NASDAQ:NEOG) and STAAR Surgical (NASDAQ:STAA) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their earnings, analyst recommendations, valuation, risk, media sentiment, dividends, institutional ownership and profitability.

: 96.7% of Neogen shares are held by institutional investors. Comparatively, 96.7% of STAAR Surgical shares are held by institutional investors. 0.6% of Neogen shares are held by insiders. Comparatively, 0.6% of STAAR Surgical shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
: STAAR Surgical has a net margin of -33.60% compared to Neogen's net margin of -69.93%. Neogen's return on equity of 2.35% beat STAAR Surgical's return on equity.
Company Net Margins Return on Equity Return on Assets
Neogen -69.93% 2.35% 1.46%
STAAR Surgical -33.60% -10.03% -7.70%
: Neogen currently has a consensus target price of $10.67, indicating a potential upside of 16.19%. STAAR Surgical has a consensus target price of $19.93, indicating a potential downside of 28.19%. Given Neogen's stronger consensus rating and higher probable upside, equities research analysts plainly believe Neogen is more favorable than STAAR Surgical.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Neogen
1 Sell rating(s)
3 Hold rating(s)

2 Buy rating(s)

0 Strong Buy rating(s)
2.17
STAAR Surgical
2 Sell rating(s)

7 Hold rating(s)

2 Buy rating(s)

0 Strong Buy rating(s)
2.00
: Neogen has a beta of 1.84, suggesting that its share price is 84% more volatile than the S&P 500. Comparatively, STAAR Surgical has a beta of 1.2, suggesting that its share price is 20% more volatile than the S&P 500.
: STAAR Surgical has lower revenue, but higher earnings than Neogen. STAAR Surgical is trading at a lower price-to-earnings ratio than Neogen, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Neogen $894.66M 2.23 -$1.09B -$2.80 N/A
STAAR Surgical $239.44M 5.77 -$80.45M -$1.63 N/A
: In the previous week, Neogen had 12 more articles in the media than STAAR Surgical. MarketBeat recorded 15 mentions for Neogen and 3 mentions for STAAR Surgical. STAAR Surgical's average media sentiment score of 0.00 beat Neogen's score of -0.20 indicating that STAAR Surgical is being referred to more favorably in the news media.
Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Neogen
2 Very Positive mention(s)
2 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
STAAR Surgical
0 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Company	Net Margins	Return on Equity	Return on Assets
Neogen	-69.93%	2.35%	1.46%
STAAR Surgical	-33.60%	-10.03%	-7.70%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Neogen	1 Sell rating(s)	3 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.17
STAAR Surgical	2 Sell rating(s)	7 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.00

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Neogen	$894.66M	2.23	-$1.09B	-$2.80	N/A
STAAR Surgical	$239.44M	5.77	-$80.45M	-$1.63	N/A

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Neogen	2 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
STAAR Surgical	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Neogen beats STAAR Surgical on 9 of the 15 factors compared between the two stocks.

Get STAAR Surgical News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding STAA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

STAA vs. The Competition

Export

Metric	STAAR Surgical	MED/DENTAL Industry	Medical Sector	NASDAQ Exchange
Market Cap	$1.37B	$15.63B	$6.28B	$11.90B
Dividend Yield	N/A	2.02%	2.74%	5.26%
P/E Ratio	-17.02	15.97	29.18	27.35
Price / Sales	5.77	2.18	507.94	85.59
Price / Cash	N/A	12.93	43.42	54.56
Price / Book	4.01	2.99	9.85	6.79
Net Income	-$80.45M	$452.74M	$3.55B	$332.68M
7 Day Performance	5.27%	1.19%	2.30%	2.55%
1 Month Performance	31.58%	6.40%	6.45%	9.36%
1 Year Performance	42.75%	-1.59%	44.89%	45.22%

STAAR Surgical Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
STAA STAAR Surgical	1.2389 of 5 stars	$27.75 +1.1%	$19.93 -28.2%	+48.9%	$1.37B	$239.44M	N/A	1,211	Upcoming Earnings
MMSI Merit Medical Systems	4.4555 of 5 stars	$62.01 flat	$92.80 +49.7%	-33.6%	$3.70B	$1.54B	26.84	7,500	Earnings Report High Trading Volume
ICUI ICU Medical	3.3514 of 5 stars	$118.67 -0.2%	$169.00 +42.4%	-11.0%	$2.97B	$2.23B	5,936.47	13,000
HAE Haemonetics	3.9801 of 5 stars	$55.23 -6.8%	$82.78 +49.9%	-17.5%	$2.75B	$1.36B	15.22	3,023	News Coverage
XRAY DENTSPLY SIRONA	4.7015 of 5 stars	$11.20 -5.2%	$13.91 +24.2%	-16.7%	$2.37B	$3.68B	N/A	14,000	Trending News Earnings Report Analyst Forecast

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:STAA) was last updated on 5/7/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

STAAR Surgical (STAA) Competitors

STAA vs. MMSI, ICUI, HAE, XRAY, and NEOG

How does STAAR Surgical compare to Merit Medical Systems?

Summary

How does STAAR Surgical compare to ICU Medical?

Summary

How does STAAR Surgical compare to Haemonetics?

Summary

How does STAAR Surgical compare to DENTSPLY SIRONA?

Summary

How does STAAR Surgical compare to Neogen?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

STAA vs. The Competition

STAAR Surgical Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

STAAR Surgical (STAA) Competitors

STAA vs. MMSI, ICUI, HAE, XRAY, and NEOG

How does STAAR Surgical compare to Merit Medical Systems?

Summary

How does STAAR Surgical compare to ICU Medical?

Summary

How does STAAR Surgical compare to Haemonetics?

Summary

How does STAAR Surgical compare to DENTSPLY SIRONA?

Summary

How does STAAR Surgical compare to Neogen?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

STAA vs. The Competition

STAAR Surgical Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools